Medical Dermatology
Conference Coverage
Pyoderma gangrenosum: Understanding the difficult diagnosis
Ulcerative disorder can be mistaken for other conditions, dermatologist says.
Conference Coverage
Cross-sectional study finds chronic skin conditions have highest opioid prescribing rates
Although patients older than 65 years accounted for 36.2% of visits to dermatologists, 58.5% of opioids prescribed by dermatologists were in...
Conference Coverage
Lenabasum missed mark for systemic sclerosis but may show promise for adjunctive therapy
The negative trial findings are primarily due to participants’ continued use of background immunosuppressive therapy during the trial, but...
Conference Coverage
Intravenous immunoglobulin controls dermatomyositis in phase 3 trial
Intravenous immunoglobulin was safe and effective for dermatomyositis in the first multinational, phase 3, placebo-controlled trial to evaluate...
From the Journals
Rituximab superior to mycophenolate mofetil in pemphigus vulgaris study
“The results of this trial showed that rituximab was superior to mycophenolate mofetil in producing sustained complete remission over 52 weeks.”...
Pediatric Dermatology Consult
An infant girl presents with a growing pink-red leg nodule
A 3-month-old infant presents with a poorly defined erythematous mass on the left anterior upper leg with a lumpy texture.
News from the FDA/CDC
FDA panel narrowly backs avacopan approval
The FDA is mulling whether to approve avacopan for ANCA-associated vasculitis based largely on a single trial about which the agency staff has...
Conference Coverage
In pemphigus, phase 2 results with BTK inhibitor raise hopes for phase 3 trial
The well tolerated BTK inhibitor rilzabrutinib might be the first, but not last BTK inhibitor for pemphigus vulgaris. “The improvement...
Conference Coverage
For diagnosing skin lesions, AI risks failing in skin of color
AI-aided diagnostic algorithms will not work in skin of color if machine training remains inadequate.
From the Journals
Novel BRAF-inhibitor cream ameliorates rash from EGFR inhibitors
A topical cream appears to ameliorate the acneiform rash caused by EGFR inhibitors.
Conference Coverage
Tofacitinib: Small study shows big cutaneous sarcoidosis response
“Not only did patients get better, but they were in many cases able to come off their baseline immunosuppressive regimen."